Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Martiny-Baron

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Pharmacological Research|June 6, 2007
Classical PKC isoforms in cancerGeorg Martiny-Baron, Doriano Fabbro
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
Targeting cancer with small-molecular-weight kinase inhibitorsDoriano Fabbro, Sandra W Cowan-Jacob, Henrik Möbitz, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 9, 2011
Characterization of kinase inhibitors using reverse phase protein arraysGeorg Martiny-Baron, Dorothea Haasen, Daniel D'Dorazio, et al.
Expert Opinion on Investigational Drugs|November 30, 2002
Therapies directed at vascular endothelial growth factorPaul W Manley, Georg Martiny-Baron, Jean-Marc Schlaeppi, et al.
Neoplasia (New York, N.Y.)|May 22, 2004
Inhibition of tumor growth and angiogenesis by soluble EphB4Georg Martiny-Baron, Thomas Korff, Florence Schaffner, et al.
International Journal of Molecular Medicine|September 30, 2009
Inhibition of angiogenesis in lipodermatosclerosis: implication for venous ulcer formationYared Herouy, Sebastian Kreis, Tobias Mueller, et al.
The Journal of Biological Chemistry|November 13, 2002
Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeatsUlrike Fiedler, Tanja Krissl, Stefanie Koidl, et al.
Kidney International|March 9, 2012
Podocyte EphB4 signaling helps recovery from glomerular injuryMonika Wnuk, Ruslan Hlushchuk, Mathilde Janot, et al.
Angiogenesis|August 31, 2010
The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesisGeorg Martiny-Baron, Philipp Holzer, Eric Billy, et al.
Biochimica Et Biophysica Acta|November 20, 2009
Extended kinase profile and properties of the protein kinase inhibitor nilotinibPaul W Manley, Peter Drueckes, Gabriele Fendrich, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Pharmacological Research|June 6, 2007
Classical PKC isoforms in cancerGeorg Martiny-Baron, Doriano Fabbro
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
Targeting cancer with small-molecular-weight kinase inhibitorsDoriano Fabbro, Sandra W Cowan-Jacob, Henrik Möbitz, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 9, 2011
Characterization of kinase inhibitors using reverse phase protein arraysGeorg Martiny-Baron, Dorothea Haasen, Daniel D'Dorazio, et al.
Expert Opinion on Investigational Drugs|November 30, 2002
Therapies directed at vascular endothelial growth factorPaul W Manley, Georg Martiny-Baron, Jean-Marc Schlaeppi, et al.
Neoplasia (New York, N.Y.)|May 22, 2004
Inhibition of tumor growth and angiogenesis by soluble EphB4Georg Martiny-Baron, Thomas Korff, Florence Schaffner, et al.
International Journal of Molecular Medicine|September 30, 2009
Inhibition of angiogenesis in lipodermatosclerosis: implication for venous ulcer formationYared Herouy, Sebastian Kreis, Tobias Mueller, et al.
The Journal of Biological Chemistry|November 13, 2002
Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeatsUlrike Fiedler, Tanja Krissl, Stefanie Koidl, et al.
Kidney International|March 9, 2012
Podocyte EphB4 signaling helps recovery from glomerular injuryMonika Wnuk, Ruslan Hlushchuk, Mathilde Janot, et al.
Angiogenesis|August 31, 2010
The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesisGeorg Martiny-Baron, Philipp Holzer, Eric Billy, et al.
Biochimica Et Biophysica Acta|November 20, 2009
Extended kinase profile and properties of the protein kinase inhibitor nilotinibPaul W Manley, Peter Drueckes, Gabriele Fendrich, et al.
Pageof 3